Degnan Chris bought URGN
October 8, 2025 · Form 4 insider transaction
Degnan Chris bought 4,483 shares of UroGen Pharma Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,483
Price
N/A
Total value
N/A
InsiderDegnan Chris
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 9, 2025
Shares owned after4,483
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.